Liquidia Corp (NASDAQ:LQDA)

4.05
Delayed Data
As of May 27
 +0.02 / +0.50%
Today’s Change
2.25
Today|||52-Week Range
7.78
-16.84%
Year-to-Date
Why Liquidia Stock Rose as Much as 22% Higher Today
May 26 / MotleyFool.com - Paid Partner Content
United Therapeutics (UTHR) Gains on Tyvaso DPI Approval
May 25 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close4.03
Today’s open4.05
Day’s range3.93 - 4.17
Volume57,676
Average volume (3 months)694,170
Market cap$372.6M
Data as of 4:00pm ET, 05/27/2022

Growth & Valuation

Earnings growth (last year)+65.29%
Earnings growth (this year)+31.76%
Earnings growth (next 5 years)--
Revenue growth (last year)+198.20%
P/E ratioNM
Price/Sales9.79
Price/Book4.68

Competitors

 Today’s
change
Today’s
% change
AERIAerie Pharmaceutical...-0.01-0.18%
LXRXLexicon Pharmaceutic...+0.07+4.17%
PRVBProvention Bio Inc+0.18+4.62%
VRNAVerona Pharma PLC+0.01+0.22%
Data as of 3:59pm ET, 05/27/2022

Financials

Next reporting dateAugust 9, 2022
EPS forecast (this quarter)-$0.24
Annual revenue (last year)$8.1M
Annual profit (last year)-$47.6M
Net profit margin-589.48%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Morrisville, North Carolina

Forecasts